2021 annual financial data
Neurocrine Biosciences 2021 Operating margin
Direct answer
Operating margin was 9.04%.
Operating income was 102,500,000 USD and net income was 89,600,000 USD.
Operating cash flow was 256,500,000 USD.
Get free Neurocrine Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,133,500,000 USD
- Operating income
- 102,500,000 USD
- Net income
- 89,600,000 USD
- Operating cash flow
- 256,500,000 USD